Vivendy Therapeutics' Series A Round

Vivendy Therapeutics raised a round of funding on January 14, 2008.

Vivendy Therapeutics, a start-up pharmaceutical company founded in March 2006, is focused on the development of an enzyme replacement therapy (ERT) for the treatment of Morbus Morquio (Mucopolysacchar…

Articles about Vivendy Therapeutics' Series A Round: